Breaking trianglesLooking for a good break out of this pattern and in the MACD again. Right now is retesting, we will be waiting for a bullish pattern as this can be also a fakeoutLongby CriptoJoe332
3/20/22 REGNRegeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $74.451B Current Price: $685.94 Breakout price: $687.00 Buy Zone (Top/Bottom Range): $660.50-$603.40 Price Target: $812.00-$816.40 Estimated Duration to Target: 125-130d Contract of Interest: $REGN 9/16/22 700c Trade price as of publish date: $50.35/contractLongby lord_catnip1
Poised to breakout above 625 REGNREGN is in a very tight consolidated pattern. This stock is really to make a move higher above $625. This will need considerable volume passed 625 but keeping an eye out for some news releases that instigate a move higher. Longby The_Level_Two0
REGN Support buyMajor support at 200DMA. This is traditionally a strong stock and great opportunity to buy in. Start small and scale in as it move higher. Longby The_Level_Two0
REGN: volatility squeeze?The Bollinger Band Squeeze occurs when volatility falls to low levels and the Bollinger Bands narrow. Periods of low volatility are often followed by periods of high volatility. Therefore, a volatility contraction or narrowing of the bands can foreshadow a significant advance or decline. Once the squeeze play is on, a subsequent band break signals the start of a new move. A new advance starts with a squeeze and subsequent break above the upper band. RSI leaves enough room for upside price potential. Above 600 supports a bullish trend direction. Longby Peet_Serfontein2
Degeneron This sorcery will probably end up happening a lot faster but we just copy some fractal that looks good enough to illustrate what's coming.Shortby Swoop6335
Cup and HandlePrice is not to long entry level yet which would be over the left side, or sell side of the cup. Known to be volatile like biotech tends to be. Negative volume is high showing interest. Short interest is 1.57%. Estimated earnings 2-3-22 BMO. (before market opens) There should be strong support at mid cup which is 5582.82 and at the handle low (HL) The cup depth is 223.64. No recommendation. The alligator is trying to tangle which can suggest consolidation of price. Longby lauraleaUpdated 223
$RGEN Building a Nice BaseThat base is starting to look more symmetrical with each passing day and therefore more attractive. Moved it from my watchlist to my secondary watch list this evening. Longby TaPlot1
$800 soonlooks like a cup and handle in the weekly re-accumulation phase in the daily its undervalued stock that has a room to run 20% at least Longby fghareeb0
Regeneron Announces $3 Billion Share Repurchase Program!!!REGN: Regeneron Pharmaceuticals, Inc. 2021-11-12 16:00:00 Regeneron Announces $3 Billion Share Repurchase ProgramLongby JetEquities0
REGN RESIST LINE$544 REGN Resist line 3 year chart trend line of bottoms shows $544 as resist Line…If it breaks then we have a problem by stockology22
Incoming Buying OpportunityREGN potentially coming into $460 range again. R/R heavy in favor going long if it falls to this level. Would keep watch. Recent phase 3 results re:COVID19 by Dr_Tabb0
Regeneron Announces Encouraging Topline Phase 2 Data of High-dosREGN: Regeneron Pharmaceuticals, Inc. 2021-08-24 07:00:00 Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular DegenerationLongby RocketTickers0
Taking profits on REGN swing tradeIt seems like we've ended an impulsive cycle of 5 waves, now expecting a three waves pullback. Either that or what it seems to be an ending diagonal is instead a leading diagonal (1st of 5th): then we should see further upside. Since I'm up 37% on my trade, I'm taking profits. Disclaimer: this is not financial advice. I'm an amateur investor. Trade at your own risk.by Fidia4
Regeneron - Gaslighting FOMO - Valuation Matters - StonksStonk. #MSOgang small caps. Investing ain't easy. Rule # whatever, don't be cute. Vaccine play is overplayed. 2021 is not a repeat of '20. A rising rate environment is in works. $GNLN #thegem #cannabisreform Shortby EpicEconomics0
IS THE REGENERON PHARMACEUTICALS INC IS READY FOR A NEW ALL-TIMEIs Regeneron Pharmaceuticals ready for a new all-time high, or will it test again the previous one at $620 from October 2020 and confirm it as a strong resistance? Regeneron Pharmaceuticals is a leading-edge biotech and pharmaceutical company that focuses on cytokines and tyrosine kinase receptors at the cellular level. First, Regeneron developed an experimental antibody cocktail to treat COVID-19 called REGN-COV2. This treatment was granted emergency use authorization by the FDA and was even provided to former President Trump when he contracted the virus. They have a diverse product offering outside of COVID-19 offerings and some exciting possibilities in their pipeline. Also, they recently announced a new partnership with the British pharmaceutical company AstraZeneca to research and developed small molecule compounds targeting the GPR75 gene. This is also promising because the Regeneron Genetics Center discovered the GPR75 gene to be a key factor in developing obesity, a disease that over 650 million people suffer from around the world. It is inspiring when you consider that the comorbidities associated with obesity can manifest as a significant cost to insurance companies, making the drug more marketable. Over the past couple of years, the growth of the generics industry has been staggering, and Regeneron is fast becoming a major player. On August 5, the company announced its results for the second quarter of the year by beating the forecast results and publishing a better revenue and EPS. Fundamentally the company looks ready for a new all-time high, but dividends and share purchases are the areas where the company becomes a bit complicated. It is focused on its funds on R&D and has done exceptionally well, but it does not currently pay a dividend, and the net buyback rate is low. It is interesting how the investors will react at these price levels because it looks like that the price revert and confirm the $620 price level as a strong resistance. But if this correction in the long uptrend is temporary, the price easily reaches the previous all-time high at $666 and try to break through it. But it is also possible to picture the graph we saw between October and December last year in a downward direction to the price levels of $540 or far on South to $467. Looking at oscillator indicators, we can see that the correction starts from the RSI overbought zone. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carry a high-risk level. By registering and signing up, any client affirms their understanding of their accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals; therefore, it cannot be held liable nor guarantee any profits or losses. by legacyFXofficial4
REGNREGN - reported strong earnings. Bouncing off the daily 20 EMA. Daily and weekly momentum indicators are positive. A close above $598.50 would be bullish.Longby Trade_with_confidence1
REGN LONGI'd enter Regeneron here at 580$ / share . Risking 28$ in my position . SL set at 552. Price Targets are listed on chart : Previous ATH (664) , 800$ . R:R is in our great favor as price can go $200 to the upside while only risking $28 per share. Enter at own risk but I believe this is a great play. Longby tslatrades2
ridethepig | Regeneron Pharmaceuticals📌 REGN pipeline (with particular focus on the early stages) CEMIPLIMAB, REGN3767, REGN1979, REGN4018, REGN5458, REGN5459, REGN5678, REGN5093, REGN5713-5714-5715 and REGN-COV2 all have a lot of potential with particular focus around oncology. As can be see with GILD, the covid positioning has already moved on a lot: we are ready to play chapter II and REGN is a name worth considering for those looking to add single stock opps to their portfolio. Buyers are clearly exercising control here on the Monthly chart at $600. To the topside there is very little in-between here and $1,000 as the next big level. Thanks as usual for keeping the feedback coming 👍 or 👎Longby ridethepigUpdated 20
REGN trend up, daily squeezeThis is a name that floated into my brain when I got quiet today and it looks like a good candidate for a daily squeeze to fire long. My dowsing suggests an uptrend, so let's just watch. This isn't a stock I really follow.Longby JenRzUpdated 1
REGN Bullish Trend LineBullish trend line bounce. The green "T" on the chart indicates a tweezer pattern which sometimes is a reversal. Appears to be finding some support, this stock is overall bullish. Thanks for viewing!Longby justinsandell0